Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity

The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection–triggered immune dysregulation and aberrant activation of platelets. We combined histological analyses u...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 119; no. 33; pp. 1 - 11
Main Authors Iwamura, Chiaki, Hirahara, Kiyoshi, Kiuchi, Masahiro, Ikehara, Sanae, Azuma, Kazuhiko, Shimada, Tadanaga, Kuriyama, Sachiko, Ohki, Syota, Yamamoto, Emiri, Inaba, Yosuke, Shiko, Yuki, Aoki, Ami, Kokubo, Kota, Hirasawa, Rui, Hishiya, Takahisa, Tsuji, Kaori, Nagaoka, Tetsutaro, Ishikawa, Satoru, Kojima, Akira, Mito, Haruki, Hase, Ryota, Kasahara, Yasunori, Kuriyama, Naohide, Tsukamoto, Tetsuya, Nakamura, Sukeyuki, Urushibara, Takashi, Kaneda, Satoru, Sakao, Seiichiro, Tobiume, Minoru, Suzuki, Yoshio, Tsujiwaki, Mitsuhiro, Kubo, Terufumi, Hasegawa, Tadashi, Nakase, Hiroshi, Nishida, Osamu, Takahashi, Kazuhisa, Baba, Komei, Iizumi, Yoko, Okazaki, Toshiya, Kimura, Motoko Y., Yoshino, Ichiro, Igari, Hidetoshi, Nakajima, Hiroshi, Suzuki, Takuji, Hanaoka, Hideki, Nakada, Taka-aki, Ikehara, Yuzuru, Yokote, Koutaro, Nakayama, Toshinori
Format Journal Article
LanguageEnglish
Published Washington National Academy of Sciences 16.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection–triggered immune dysregulation and aberrant activation of platelets. We combined histological analyses using field emission scanning electron microscopy with energy-dispersive X-ray spectroscopy analyses of the lungs from autopsy samples and single-cell RNA sequencing of peripheral blood mononuclear cells to investigate the pathogenesis of vasculitis and immunothrombosis in COVID-19. We found that SARS-CoV-2 accumulated in the pulmonary vessels, causing exudative vasculitis accompanied by the emergence of thrombospondin-1–expressing noncanonical monocytes and the formation of myosin light chain 9 (Myl9)–containing microthrombi in the lung of COVID-19 patients with fatal disease. The amount of plasma Myl9 in COVID-19 was correlated with the clinical severity, and measuring plasma Myl9 together with other markers allowed us to predict the severity of the disease more accurately. This study provides detailed insight into the pathogenesis of vasculitis and immunothrombosis, which may lead to optimal medical treatment for COVID-19.
AbstractList The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection–triggered immune dysregulation and aberrant activation of platelets. We combined histological analyses using field emission scanning electron microscopy with energy-dispersive X-ray spectroscopy analyses of the lungs from autopsy samples and single-cell RNA sequencing of peripheral blood mononuclear cells to investigate the pathogenesis of vasculitis and immunothrombosis in COVID-19. We found that SARS-CoV-2 accumulated in the pulmonary vessels, causing exudative vasculitis accompanied by the emergence of thrombospondin-1–expressing noncanonical monocytes and the formation of myosin light chain 9 (Myl9)–containing microthrombi in the lung of COVID-19 patients with fatal disease. The amount of plasma Myl9 in COVID-19 was correlated with the clinical severity, and measuring plasma Myl9 together with other markers allowed us to predict the severity of the disease more accurately. This study provides detailed insight into the pathogenesis of vasculitis and immunothrombosis, which may lead to optimal medical treatment for COVID-19.
The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-triggered immune dysregulation and aberrant activation of platelets. We combined histological analyses using field emission scanning electron microscopy with energy-dispersive X-ray spectroscopy analyses of the lungs from autopsy samples and single-cell RNA sequencing of peripheral blood mononuclear cells to investigate the pathogenesis of vasculitis and immunothrombosis in COVID-19. We found that SARS-CoV-2 accumulated in the pulmonary vessels, causing exudative vasculitis accompanied by the emergence of thrombospondin-1-expressing noncanonical monocytes and the formation of myosin light chain 9 (Myl9)-containing microthrombi in the lung of COVID-19 patients with fatal disease. The amount of plasma Myl9 in COVID-19 was correlated with the clinical severity, and measuring plasma Myl9 together with other markers allowed us to predict the severity of the disease more accurately. This study provides detailed insight into the pathogenesis of vasculitis and immunothrombosis, which may lead to optimal medical treatment for COVID-19.The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-triggered immune dysregulation and aberrant activation of platelets. We combined histological analyses using field emission scanning electron microscopy with energy-dispersive X-ray spectroscopy analyses of the lungs from autopsy samples and single-cell RNA sequencing of peripheral blood mononuclear cells to investigate the pathogenesis of vasculitis and immunothrombosis in COVID-19. We found that SARS-CoV-2 accumulated in the pulmonary vessels, causing exudative vasculitis accompanied by the emergence of thrombospondin-1-expressing noncanonical monocytes and the formation of myosin light chain 9 (Myl9)-containing microthrombi in the lung of COVID-19 patients with fatal disease. The amount of plasma Myl9 in COVID-19 was correlated with the clinical severity, and measuring plasma Myl9 together with other markers allowed us to predict the severity of the disease more accurately. This study provides detailed insight into the pathogenesis of vasculitis and immunothrombosis, which may lead to optimal medical treatment for COVID-19.
Elucidation of the pathology triggered by SARS-CoV-2 infection is essential to control the pandemic. We found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) accumulates in the pulmonary vessels, causing exudative vasculitis accompanied by the emergence of noncanonical monocytes that specifically produce a platelet activating factor, thrombospondin-1, and the formation of myosin light chain 9 (Myl9)–containing microthrombi in the lungs of coronavirus disease 2019 (COVID-19) patients with fatal disease. More interestingly, we demonstrate that SARS-CoV-2–induced platelet activation causes an increase in the plasma Myl9 level, which is closely correlated with clinical severity. The measurement of plasma Myl9 with other markers allowed us to diagnose the severity of the disease more accurately, which is crucial for providing appropriate medical care for COVID-19 patients. The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection–triggered immune dysregulation and aberrant activation of platelets. We combined histological analyses using field emission scanning electron microscopy with energy-dispersive X-ray spectroscopy analyses of the lungs from autopsy samples and single-cell RNA sequencing of peripheral blood mononuclear cells to investigate the pathogenesis of vasculitis and immunothrombosis in COVID-19. We found that SARS-CoV-2 accumulated in the pulmonary vessels, causing exudative vasculitis accompanied by the emergence of thrombospondin-1–expressing noncanonical monocytes and the formation of myosin light chain 9 (Myl9)–containing microthrombi in the lung of COVID-19 patients with fatal disease. The amount of plasma Myl9 in COVID-19 was correlated with the clinical severity, and measuring plasma Myl9 together with other markers allowed us to predict the severity of the disease more accurately. This study provides detailed insight into the pathogenesis of vasculitis and immunothrombosis, which may lead to optimal medical treatment for COVID-19.
Author Sakao, Seiichiro
Nakajima, Hiroshi
Shiko, Yuki
Tobiume, Minoru
Urushibara, Takashi
Aoki, Ami
Yoshino, Ichiro
Nakayama, Toshinori
Suzuki, Takuji
Shimada, Tadanaga
Tsujiwaki, Mitsuhiro
Nakada, Taka-aki
Suzuki, Yoshio
Iizumi, Yoko
Nishida, Osamu
Takahashi, Kazuhisa
Hishiya, Takahisa
Kaneda, Satoru
Hirasawa, Rui
Tsukamoto, Tetsuya
Mito, Haruki
Hasegawa, Tadashi
Kasahara, Yasunori
Kimura, Motoko Y.
Nakase, Hiroshi
Ohki, Syota
Okazaki, Toshiya
Igari, Hidetoshi
Kojima, Akira
Hirahara, Kiyoshi
Nagaoka, Tetsutaro
Ikehara, Sanae
Iwamura, Chiaki
Nakamura, Sukeyuki
Kokubo, Kota
Ikehara, Yuzuru
Hanaoka, Hideki
Azuma, Kazuhiko
Yamamoto, Emiri
Kubo, Terufumi
Kuriyama, Naohide
Tsuji, Kaori
Kiuchi, Masahiro
Baba, Komei
Kuriyama, Sachiko
Ishikawa, Satoru
Inaba, Yosuke
Hase, Ryota
Yokote, Koutaro
Author_xml – sequence: 1
  givenname: Chiaki
  surname: Iwamura
  fullname: Iwamura, Chiaki
– sequence: 2
  givenname: Kiyoshi
  surname: Hirahara
  fullname: Hirahara, Kiyoshi
– sequence: 3
  givenname: Masahiro
  surname: Kiuchi
  fullname: Kiuchi, Masahiro
– sequence: 4
  givenname: Sanae
  surname: Ikehara
  fullname: Ikehara, Sanae
– sequence: 5
  givenname: Kazuhiko
  surname: Azuma
  fullname: Azuma, Kazuhiko
– sequence: 6
  givenname: Tadanaga
  surname: Shimada
  fullname: Shimada, Tadanaga
– sequence: 7
  givenname: Sachiko
  surname: Kuriyama
  fullname: Kuriyama, Sachiko
– sequence: 8
  givenname: Syota
  surname: Ohki
  fullname: Ohki, Syota
– sequence: 9
  givenname: Emiri
  surname: Yamamoto
  fullname: Yamamoto, Emiri
– sequence: 10
  givenname: Yosuke
  surname: Inaba
  fullname: Inaba, Yosuke
– sequence: 11
  givenname: Yuki
  surname: Shiko
  fullname: Shiko, Yuki
– sequence: 12
  givenname: Ami
  surname: Aoki
  fullname: Aoki, Ami
– sequence: 13
  givenname: Kota
  surname: Kokubo
  fullname: Kokubo, Kota
– sequence: 14
  givenname: Rui
  surname: Hirasawa
  fullname: Hirasawa, Rui
– sequence: 15
  givenname: Takahisa
  surname: Hishiya
  fullname: Hishiya, Takahisa
– sequence: 16
  givenname: Kaori
  surname: Tsuji
  fullname: Tsuji, Kaori
– sequence: 17
  givenname: Tetsutaro
  surname: Nagaoka
  fullname: Nagaoka, Tetsutaro
– sequence: 18
  givenname: Satoru
  surname: Ishikawa
  fullname: Ishikawa, Satoru
– sequence: 19
  givenname: Akira
  surname: Kojima
  fullname: Kojima, Akira
– sequence: 20
  givenname: Haruki
  surname: Mito
  fullname: Mito, Haruki
– sequence: 21
  givenname: Ryota
  surname: Hase
  fullname: Hase, Ryota
– sequence: 22
  givenname: Yasunori
  surname: Kasahara
  fullname: Kasahara, Yasunori
– sequence: 23
  givenname: Naohide
  surname: Kuriyama
  fullname: Kuriyama, Naohide
– sequence: 24
  givenname: Tetsuya
  surname: Tsukamoto
  fullname: Tsukamoto, Tetsuya
– sequence: 25
  givenname: Sukeyuki
  surname: Nakamura
  fullname: Nakamura, Sukeyuki
– sequence: 26
  givenname: Takashi
  surname: Urushibara
  fullname: Urushibara, Takashi
– sequence: 27
  givenname: Satoru
  surname: Kaneda
  fullname: Kaneda, Satoru
– sequence: 28
  givenname: Seiichiro
  surname: Sakao
  fullname: Sakao, Seiichiro
– sequence: 29
  givenname: Minoru
  surname: Tobiume
  fullname: Tobiume, Minoru
– sequence: 30
  givenname: Yoshio
  surname: Suzuki
  fullname: Suzuki, Yoshio
– sequence: 31
  givenname: Mitsuhiro
  surname: Tsujiwaki
  fullname: Tsujiwaki, Mitsuhiro
– sequence: 32
  givenname: Terufumi
  surname: Kubo
  fullname: Kubo, Terufumi
– sequence: 33
  givenname: Tadashi
  surname: Hasegawa
  fullname: Hasegawa, Tadashi
– sequence: 34
  givenname: Hiroshi
  surname: Nakase
  fullname: Nakase, Hiroshi
– sequence: 35
  givenname: Osamu
  surname: Nishida
  fullname: Nishida, Osamu
– sequence: 36
  givenname: Kazuhisa
  surname: Takahashi
  fullname: Takahashi, Kazuhisa
– sequence: 37
  givenname: Komei
  surname: Baba
  fullname: Baba, Komei
– sequence: 38
  givenname: Yoko
  surname: Iizumi
  fullname: Iizumi, Yoko
– sequence: 39
  givenname: Toshiya
  surname: Okazaki
  fullname: Okazaki, Toshiya
– sequence: 40
  givenname: Motoko Y.
  surname: Kimura
  fullname: Kimura, Motoko Y.
– sequence: 41
  givenname: Ichiro
  surname: Yoshino
  fullname: Yoshino, Ichiro
– sequence: 42
  givenname: Hidetoshi
  surname: Igari
  fullname: Igari, Hidetoshi
– sequence: 43
  givenname: Hiroshi
  surname: Nakajima
  fullname: Nakajima, Hiroshi
– sequence: 44
  givenname: Takuji
  surname: Suzuki
  fullname: Suzuki, Takuji
– sequence: 45
  givenname: Hideki
  surname: Hanaoka
  fullname: Hanaoka, Hideki
– sequence: 46
  givenname: Taka-aki
  surname: Nakada
  fullname: Nakada, Taka-aki
– sequence: 47
  givenname: Yuzuru
  surname: Ikehara
  fullname: Ikehara, Yuzuru
– sequence: 48
  givenname: Koutaro
  surname: Yokote
  fullname: Yokote, Koutaro
– sequence: 49
  givenname: Toshinori
  surname: Nakayama
  fullname: Nakayama, Toshinori
BookMark eNp1kU9rVDEUxYNU7LS6diU8cOPmtfn7kmyEMq1aqBSsdhvykkwnw5tkTPIezs6le7-hn8SMUxULrgI3v3Mu95wjcBBicAA8R_AEQU5ON0HnE4whoYQjJB-BGYIStR2V8ADMIMS8FRTTQ3CU8wpCKJmAT8AhYUIyjroZ-HYxuEkXZ5v320E2yS0GZ0puytL9mrQmhqJ98OGuWXuTYlmmuO5940Nzc_bhpp3H2xb_-PrdBzuaajOMlXRfRquLn1wz6WzGwRefGx1ss0nO-p3__Pr28rxFsslucsmX7VPweKGH7J7dv8fg05uLj_N37dX128v52VVrqOhKiyHltJOWUaKN5MxwA51YcId7SyDtqRUMO4GEED1ipkNcWsI1pj0WmjFIjsHrve9m7NfOGhdK0oPaJL_Waaui9urfn-CX6i5OShIhEKbV4NW9QYqfR5eLWvts3DDo4OKYFe4kwxJD1lX05QN0FccU6nkKc0gJZBiTSrE9VdPNuTagjC81vbjb7weFoNp1rXZdq79dV93pA93vI_6veLFXrHKJ6Q-OOYZdDYz8BJryt_c
CitedBy_id crossref_primary_10_3390_ijms25063280
crossref_primary_10_1016_j_clinsp_2025_100584
crossref_primary_10_1016_j_cyto_2024_156583
crossref_primary_10_1002_jmv_28847
crossref_primary_10_1016_j_semcdb_2023_05_008
crossref_primary_10_1007_s10875_024_01708_7
crossref_primary_10_1177_17534666231162252
crossref_primary_10_3390_biomedicines11082301
crossref_primary_10_1016_j_jiac_2022_12_004
crossref_primary_10_3390_microorganisms12030459
crossref_primary_10_1007_s00595_024_02967_y
crossref_primary_10_1093_neuonc_noae234
crossref_primary_10_1038_s41598_024_68433_4
crossref_primary_10_3389_fimmu_2022_1036672
crossref_primary_10_1007_s11604_023_01466_3
crossref_primary_10_3390_ijms241512177
Cites_doi 10.1038/s41586-020-2700-3
10.1016/j.immuni.2021.03.005
10.3390/ijms222011028
10.1126/sciadv.abe3024
10.1038/s41586-020-2588-y
10.1126/science.abd4585
10.1056/NEJMra2026131
10.1161/CIRCULATIONAHA.120.048488
10.1016/S2665-9913(20)30275-7
10.3389/fimmu.2020.594297
10.1016/S2213-2600(20)30243-5
10.1016/S2352-3018(21)00151-X
10.1126/science.abc6027
10.1126/scitranslmed.abj7790
10.1056/NEJMoa2015432
10.1016/S1473-3099(21)00318-2
10.1126/science.abc8511
10.1016/S0140-6736(21)02867-1
10.1056/NEJMc2114706
10.1182/blood-2008-06-165845
10.1084/jem.20201129
10.1126/science.abd4570
10.1002/rcr2.912
10.1146/annurev-immunol-042617-053119
10.3389/fimmu.2021.665773
10.1016/S2352-3026(20)30145-9
10.1038/s41586-022-04447-0
10.1001/jamacardio.2020.7308
10.1182/blood.2020005382
10.1016/S0140-6736(20)30937-5
10.1371/journal.pntd.0009921
10.1001/jama.2020.16349
10.1016/S0140-6736(20)31748-7
10.1016/j.blre.2020.100761
10.1126/sciimmunol.abl4340
10.1007/s00134-020-06062-x
10.3389/fimmu.2021.589095
10.1126/sciimmunol.aaf9154
10.1182/blood.2020007008
10.1016/S2665-9913(20)30420-3
10.1038/s41591-020-0901-9
10.1182/blood-2010-01-265561
10.1016/S0140-6736(20)30566-3
10.1136/thoraxjnl-2020-216243
10.1182/bloodadvances.2020003568
10.1111/imr.12559
10.1084/jem.20211381
10.1016/j.ajpath.2021.05.007
10.1073/pnas.2010229117
10.1136/bmj.n436
10.1016/S2666-5247(21)00237-8
10.1182/blood-2014-06-581942
10.1111/jth.15409
ContentType Journal Article
Copyright Copyright © 2022 the Author(s)
Copyright National Academy of Sciences Aug 16, 2022
Copyright © 2022 the Author(s). Published by PNAS. 2022
Copyright_xml – notice: Copyright © 2022 the Author(s)
– notice: Copyright National Academy of Sciences Aug 16, 2022
– notice: Copyright © 2022 the Author(s). Published by PNAS. 2022
DBID AAYXX
CITATION
7QG
7QL
7QP
7QR
7SN
7SS
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
DOI 10.1073/pnas.2203437119
DatabaseName CrossRef
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
Ecology Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Entomology Abstracts
Genetics Abstracts
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
Virology and AIDS Abstracts
MEDLINE - Academic


DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
EISSN 1091-6490
EndPage 11
ExternalDocumentID PMC9388124
10_1073_pnas_2203437119
27206888
GrantInformation_xml – fundername: AMED-PRIME
  grantid: JP20gm6110005
– fundername: Granrs-in aid for scentific research (S)
  grantid: JP19H05650
– fundername: Grants-in aid for scientific research (C)
  grantid: 20K08769
– fundername: Practical Research Project for Allergic Diseases and Immunology from the Japan Agency for Medical Research and Development
  grantid: JP21ek0410082
– fundername: JST FOREST Project
  grantid: JPMJFR200R
– fundername: Transformative Research Areas (B)
  grantid: JP21H05121
– fundername: AMED-SENTAN project
  grantid: JP19hm0102069h001
– fundername: Grants-in aid for scientific research (C)
  grantid: 22K15484
– fundername: Practical Research Project for Allergic Diseases and Immunology from the Japan Agency for Medical Research and Development
  grantid: Nos. JP21ek0410060
– fundername: JST-Moonshot R&D
  grantid: JPMJMS2025
GroupedDBID ---
-DZ
-~X
.55
0R~
123
29P
2FS
2WC
4.4
53G
5RE
5VS
85S
AACGO
AAFWJ
AANCE
ABOCM
ABPLY
ABPPZ
ABTLG
ABZEH
ACGOD
ACIWK
ACNCT
ACPRK
AENEX
AFFNX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BKOMP
CS3
D0L
DIK
DU5
E3Z
EBS
F5P
FRP
GX1
H13
HH5
HYE
JENOY
JLS
JSG
JST
KQ8
L7B
LU7
N9A
N~3
O9-
OK1
PNE
PQQKQ
R.V
RHI
RNA
RNS
RPM
RXW
SJN
TAE
TN5
UKR
W8F
WH7
WOQ
WOW
X7M
XSW
Y6R
YBH
YKV
YSK
ZCA
~02
~KM
AAYXX
CITATION
7QG
7QL
7QP
7QR
7SN
7SS
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
2AX
5PM
ABBHK
AEUPB
AEXZC
DCCCD
IPSME
JAAYA
JBMMH
JHFFW
JKQEH
JLXEF
JPM
SA0
ID FETCH-LOGICAL-c486t-2047469d543ac975c7c0e8f7e2bd304b4d852e81888b15c6179d37a24b28a5503
ISSN 0027-8424
1091-6490
IngestDate Thu Aug 21 18:42:24 EDT 2025
Fri Jul 11 13:43:05 EDT 2025
Mon Jun 30 07:58:04 EDT 2025
Thu Apr 24 23:12:41 EDT 2025
Tue Jul 01 01:03:21 EDT 2025
Thu May 29 08:51:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 33
Language English
License This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c486t-2047469d543ac975c7c0e8f7e2bd304b4d852e81888b15c6179d37a24b28a5503
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author contributions: C.I., K.H., M.K., and T. Nakayama designed research; C.I., M.K., S. Ikehara, K.A., T. Shimada, S. Kuriyama, S.O., E.Y., A.A., K.K., R. Hirasawa, T. Hishiya, K. Tsuji, T. Nagaoka, S. Ishikawa, A.K., H.M., R. Hase, Y.K., N.K., T.T., S.N., T.U., S. Kaneda, S.S., M. Tobiume, Y. Suzuki, M. Tsujiwaki, T.K., T. Hasegawa, H. Nakase, O.N., K. Takahashi, K.B., Y. Iizumi, T.O., I.Y., H.I., H. Nakajima, T. Suzuki, T.-a.N., Y. Ikehara, and K.Y. performed research; C.I., K.H., Y. Inaba, Y. Shiko, M.Y.K., H.H., Y. Ikehara, and T. Nakayama analyzed data; and C.I., K.H., and T. Nakayama wrote the paper.
Edited by Max Cooper, Emory University, Atlanta, GA; received February 25, 2022; accepted June 22, 2022
ORCID 0000-0002-8785-5612
0000-0001-5749-4118
0000-0001-8595-9381
0000-0002-8659-2873
0000-0002-9128-9449
0000-0002-3859-9659
0000-0001-6896-1981
0000-0003-3837-2785
0000-0002-1434-2007
0000-0001-9110-2915
0000-0002-0799-3581
0000-0002-5607-5066
0000-0002-5958-0148
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC9388124
PMID 35895716
PQID 2704305223
PQPubID 42026
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9388124
proquest_miscellaneous_2695292056
proquest_journals_2704305223
crossref_citationtrail_10_1073_pnas_2203437119
crossref_primary_10_1073_pnas_2203437119
jstor_primary_27206888
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-08-16
PublicationDateYYYYMMDD 2022-08-16
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-16
  day: 16
PublicationDecade 2020
PublicationPlace Washington
PublicationPlace_xml – name: Washington
PublicationTitle Proceedings of the National Academy of Sciences - PNAS
PublicationYear 2022
Publisher National Academy of Sciences
Publisher_xml – name: National Academy of Sciences
References e_1_3_4_3_2
e_1_3_4_1_2
e_1_3_4_9_2
e_1_3_4_7_2
e_1_3_4_40_2
e_1_3_4_5_2
e_1_3_4_23_2
e_1_3_4_44_2
e_1_3_4_21_2
e_1_3_4_42_2
e_1_3_4_27_2
e_1_3_4_48_2
e_1_3_4_25_2
e_1_3_4_46_2
e_1_3_4_29_2
e_1_3_4_30_2
e_1_3_4_51_2
e_1_3_4_11_2
e_1_3_4_34_2
e_1_3_4_55_2
e_1_3_4_32_2
e_1_3_4_53_2
e_1_3_4_15_2
e_1_3_4_38_2
e_1_3_4_13_2
e_1_3_4_36_2
e_1_3_4_19_2
e_1_3_4_17_2
e_1_3_4_2_2
e_1_3_4_8_2
e_1_3_4_41_2
e_1_3_4_6_2
e_1_3_4_4_2
e_1_3_4_22_2
e_1_3_4_45_2
e_1_3_4_20_2
e_1_3_4_43_2
e_1_3_4_26_2
e_1_3_4_49_2
e_1_3_4_24_2
e_1_3_4_47_2
e_1_3_4_28_2
e_1_3_4_52_2
e_1_3_4_50_2
e_1_3_4_12_2
e_1_3_4_33_2
e_1_3_4_54_2
e_1_3_4_10_2
e_1_3_4_31_2
e_1_3_4_16_2
e_1_3_4_37_2
e_1_3_4_14_2
e_1_3_4_35_2
e_1_3_4_18_2
e_1_3_4_39_2
References_xml – ident: e_1_3_4_16_2
  doi: 10.1038/s41586-020-2700-3
– ident: e_1_3_4_18_2
  doi: 10.1016/j.immuni.2021.03.005
– ident: e_1_3_4_47_2
  doi: 10.3390/ijms222011028
– ident: e_1_3_4_1_2
  doi: 10.1126/sciadv.abe3024
– ident: e_1_3_4_14_2
  doi: 10.1038/s41586-020-2588-y
– ident: e_1_3_4_8_2
  doi: 10.1126/science.abd4585
– ident: e_1_3_4_39_2
  doi: 10.1056/NEJMra2026131
– ident: e_1_3_4_44_2
  doi: 10.1161/CIRCULATIONAHA.120.048488
– ident: e_1_3_4_13_2
  doi: 10.1016/S2665-9913(20)30275-7
– ident: e_1_3_4_34_2
  doi: 10.3389/fimmu.2020.594297
– ident: e_1_3_4_36_2
  doi: 10.1016/S2213-2600(20)30243-5
– ident: e_1_3_4_6_2
  doi: 10.1016/S2352-3018(21)00151-X
– ident: e_1_3_4_12_2
  doi: 10.1126/science.abc6027
– ident: e_1_3_4_55_2
– ident: e_1_3_4_19_2
  doi: 10.1126/scitranslmed.abj7790
– ident: e_1_3_4_38_2
  doi: 10.1056/NEJMoa2015432
– ident: e_1_3_4_2_2
  doi: 10.1016/S1473-3099(21)00318-2
– ident: e_1_3_4_15_2
  doi: 10.1126/science.abc8511
– ident: e_1_3_4_3_2
  doi: 10.1016/S0140-6736(21)02867-1
– ident: e_1_3_4_11_2
  doi: 10.1056/NEJMc2114706
– ident: e_1_3_4_52_2
  doi: 10.1182/blood-2008-06-165845
– ident: e_1_3_4_41_2
  doi: 10.1084/jem.20201129
– ident: e_1_3_4_10_2
  doi: 10.1126/science.abd4570
– ident: e_1_3_4_29_2
  doi: 10.1002/rcr2.912
– ident: e_1_3_4_30_2
  doi: 10.1146/annurev-immunol-042617-053119
– ident: e_1_3_4_45_2
  doi: 10.3389/fimmu.2021.665773
– ident: e_1_3_4_23_2
  doi: 10.1016/S2352-3026(20)30145-9
– ident: e_1_3_4_9_2
  doi: 10.1038/s41586-022-04447-0
– ident: e_1_3_4_43_2
  doi: 10.1001/jamacardio.2020.7308
– ident: e_1_3_4_48_2
  doi: 10.1182/blood.2020005382
– ident: e_1_3_4_37_2
  doi: 10.1016/S0140-6736(20)30937-5
– ident: e_1_3_4_27_2
  doi: 10.1371/journal.pntd.0009921
– ident: e_1_3_4_24_2
  doi: 10.1001/jama.2020.16349
– ident: e_1_3_4_5_2
  doi: 10.1016/S0140-6736(20)31748-7
– ident: e_1_3_4_51_2
  doi: 10.1016/j.blre.2020.100761
– ident: e_1_3_4_7_2
  doi: 10.1126/sciimmunol.abl4340
– ident: e_1_3_4_22_2
  doi: 10.1007/s00134-020-06062-x
– ident: e_1_3_4_26_2
  doi: 10.3389/fimmu.2021.589095
– ident: e_1_3_4_33_2
  doi: 10.1126/sciimmunol.aaf9154
– ident: e_1_3_4_42_2
  doi: 10.1182/blood.2020007008
– ident: e_1_3_4_20_2
  doi: 10.1016/S2665-9913(20)30420-3
– ident: e_1_3_4_17_2
  doi: 10.1038/s41591-020-0901-9
– ident: e_1_3_4_31_2
  doi: 10.1182/blood-2010-01-265561
– ident: e_1_3_4_4_2
  doi: 10.1016/S0140-6736(20)30566-3
– ident: e_1_3_4_35_2
  doi: 10.1136/thoraxjnl-2020-216243
– ident: e_1_3_4_46_2
  doi: 10.1182/bloodadvances.2020003568
– ident: e_1_3_4_32_2
  doi: 10.1111/imr.12559
– ident: e_1_3_4_53_2
  doi: 10.1084/jem.20211381
– ident: e_1_3_4_21_2
  doi: 10.1016/j.ajpath.2021.05.007
– ident: e_1_3_4_40_2
  doi: 10.1073/pnas.2010229117
– ident: e_1_3_4_25_2
  doi: 10.1136/bmj.n436
– ident: e_1_3_4_28_2
  doi: 10.1016/S2666-5247(21)00237-8
– ident: e_1_3_4_49_2
  doi: 10.1182/blood-2014-06-581942
– ident: e_1_3_4_50_2
  doi: 10.1111/jth.15409
– ident: e_1_3_4_54_2
SSID ssj0009580
Score 2.4864035
Snippet The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary vascular pathology accompanied by severe acute respiratory syndrome...
Elucidation of the pathology triggered by SARS-CoV-2 infection is essential to control the pandemic. We found that severe acute respiratory syndrome...
SourceID pubmedcentral
proquest
crossref
jstor
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1
SubjectTerms Autopsies
Autopsy
Biological Sciences
Blood vessels
Coronaviruses
COVID-19
Emission analysis
Exudation
Field emission microscopy
Gene sequencing
Leukocytes (mononuclear)
Lungs
Medical treatment
Monocytes
Myosin
Pathogenesis
Peripheral blood mononuclear cells
Respiratory diseases
Scanning electron microscopy
Severe acute respiratory syndrome coronavirus 2
Thrombospondin
Vasculitis
Viral diseases
X-ray spectroscopy
Title Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity
URI https://www.jstor.org/stable/27206888
https://www.proquest.com/docview/2704305223
https://www.proquest.com/docview/2695292056
https://pubmed.ncbi.nlm.nih.gov/PMC9388124
Volume 119
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FcuGCKFCRUtAicSiKHBLvrtc-RqEopWqpSFv1Fq3tjWKROKiJgXLiyJ1_yC9hxuv1I1CpcLEi78N25vPszHrmG0Jech0x4YXK8aQCB8Vl0lGs5ztqOo25FFr08y-mxyfe6Jy_uxSXrVadIThbh93o21_zSv5HqnAO5IpZsv8g2XJSOAG_Qb5wBAnD8VYyPpjrzwpNxuPredCBtW6ex2agLYlnHIxDNxUgOgsMvMOaCIswwT2O8eDD2BkuLxzXhjsw8M4zjAaYw_vf0V-z2HCCm1hVpD6ypAJxglcZvr84fOP0gw6srRpL4NXt3NNyXVzZKIQTu-04qJJYCs2y6jid05OqJPLhF7XI8gJIGCoCNm61QY6J3ablKLlermZl01GCZV1M-tFKzZKrZTnbR23HjFWqdH2jA3xkJJ716srbhQWVm5Trrjb6Gswdx-Om4mip0AslbJBreDb-WClAtWF541Stuq7bY5xJO6zByb2xVpYRjPm3e8kmOMGkmuAOueuCv5JHmI7q7M--yYUqnsByTEn2euMOGuaRiZBt-D7NyN2aKXT2gNwvfBg6MIDcJi2dPiTbVpZ0v6Ayf_WI_LAIpYhHahFKAQ90A6G0jlCapLRC6K_vPwtsUsQmLbFJK2xSwCa12KQWm9Ri8zE5f3twNhw5Re0PJ-K-t4bXnEvuBbHgTEWBFJGMetqfSu2GMevxkMe-cDVYm74f9kUEdngQM6lcHrq-Aq-b7ZCtdJnqJ4RqDf1h_JT1FUzphUJ4OhAhD3QE5jZvk679yydRQYyP9VnmkxuE3Cb75YBPhhPm5q47uQzLfhj24MFNt8meFeqk0CgwTuYMfGCxt8mLshn0PX7EU6leZtDHCwRWmBNem8gGGMprIGN8syVNZjlzfMB8NOh3b_8AT8m96l3cI1vrq0w_AzN8HT7PIf4bX_7e0g
linkProvider ABC ChemistRy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+Myl9+reflects+the+Myl9-containing+microthrombi+in+SARS-CoV-2%E2%80%93induced+lung+exudative+vasculitis+and+predicts+COVID-19+severity&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Iwamura%2C+Chiaki&rft.au=Hirahara%2C+Kiyoshi&rft.au=Kiuchi%2C+Masahiro&rft.au=Ikehara%2C+Sanae&rft.date=2022-08-16&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=119&rft.issue=33&rft_id=info:doi/10.1073%2Fpnas.2203437119&rft.externalDBID=n%2Fa&rft.externalDocID=10_1073_pnas_2203437119
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8424&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8424&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8424&client=summon